Mazzariello Gina sold AMLX
July 9, 2026 · Form 4 insider transaction
Mazzariello Gina sold 15,000 shares of Amylyx Pharmaceuticals, Inc. at $18.32 per share, a transaction worth $274.7K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
15,000
Price
$18.32
Total value
$274.7K
InsiderMazzariello Gina
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJuly 9, 2026
Filing dateJuly 13, 2026
Shares owned after194,090
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on April 9, 2026.; The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $17.92 to $18.51. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.